More on: fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells

J Thromb Haemost. 2005 May;3(5):1112-3. doi: 10.1111/j.1538-7836.2005.01262.x.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Antiphospholipid / physiology*
  • Antiphospholipid Syndrome / drug therapy
  • Contraindications
  • Endothelium, Vascular / chemistry
  • Fatty Acids, Monounsaturated* / administration & dosage
  • Fatty Acids, Monounsaturated* / pharmacology
  • Fibrinolytic Agents / therapeutic use
  • Fluvastatin
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / administration & dosage
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / pharmacology
  • Indoles* / administration & dosage
  • Indoles* / pharmacology
  • NF-kappa B / metabolism
  • Pyridines* / administration & dosage
  • Pyridines* / pharmacology
  • Simvastatin* / administration & dosage
  • Simvastatin* / pharmacology
  • Thromboplastin / antagonists & inhibitors*
  • Thrombosis
  • Up-Regulation / drug effects

Substances

  • Antibodies, Antiphospholipid
  • Fatty Acids, Monounsaturated
  • Fibrinolytic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Indoles
  • NF-kappa B
  • Pyridines
  • Fluvastatin
  • Thromboplastin
  • Simvastatin
  • cerivastatin